ClydeSCrumpackerMD
Infectious Disease • Boston, MAProfessor of Medicine, Beth Israel Deaconess Medical Center
Dr. Crumpacker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Avenue/Dana 617
Div Of Infectious Dis
Boston, MA 02215Phone+1 617-667-5863
Education & Training
University of WashingtonResidency, Internal Medicine, 1970 - 1971
Boston University Medical CenterResidency, Internal Medicine, 1965 - 1967
Harvard Medical SchoolClass of 1965
Certifications & Licensure
MA State Medical License 1971 - 2015
Clinical Trials
- Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS
- A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure
- A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir
- Join now to see all
Publications & Presentations
PubMed
- Approaches to pandemic prevention - the chromatin vaccine.Jielin Zhang, Philip Askenase, Rudolf Jaenisch, Clyde S Crumpacker
Frontiers in Immunology. 2023-01-01 - 1 citationsSystems Vaccinology in HIV Vaccine Development.Jielin Zhang, Philip Askenase, Clyde S Crumpacker
Vaccines. 2022-09-28 - 8 citationsHIV UTR, LTR, and Epigenetic Immunity.Jielin Zhang, Clyde Crumpacker
Viruses. 2022-05-18
Press Mentions
First Responders and Medical Staff Test Positive for Coronavirus. UW Doctors Not Getting MasksMarch 3rd, 2020
Grant Support
- Mechanisms Of Vascular Injury By HCMVNational Heart, Lung, And Blood Institute2002–2005
- Combination Therapy Involving Indinavir, Zidovudine, And Lamivudine In HIVNational Center For Research Resources1998–2000
- ACTG 320--Indinavir With OPEN Label Zidovudine And LamivudineNational Center For Research Resources1996–2000
- Pharmacokinetics And Antiretroviral Activity Study Of Oral Lobucavir In HIVNational Center For Research Resources1998–1999
- CMV Resistance, Viral Burden And Clinical ProgressionNational Institute Of Allergy And Infectious Diseases1997–1999
- Valtrex (Valacyclovir Hci) For Suppression Of Recurrent Genital HerpesNational Center For Research Resources1996–1997
- Oral Ganciclovir For Prevention Of Cytomegalovirus Disease In Patients With AIDSNational Center For Research Resources1996–1997
- Comparing MK 639 And Zidovudine To MK 639 Alone And Zidovudine AloneNational Center For Research Resources1996–1997
- Monotherapy VS Combination Therapy With Nucleoside AnaloguesNational Center For Research Resources1996
- Phase I/II Dose-Finding Study Of Effects Of DAB 389 IL-2 In HIV PatientsNational Center For Research Resources1995
- Resistance Of HIV To Drugs In Patients And In Cloned RTNational Institute Of Allergy And Infectious Diseases1989–1993
- Treatment Of Recurrent Genital And Facial Oral Herpes Simplex InfectionNational Center For Research Resources1985
- Acyclovir And Recombinant Leukocyte A Interferon In Therapy Of Herpes GenitalisNational Center For Research Resources1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
